IMPEDIMED LIMITED — Earnings Release 2009

Aug 27, 2009

Appendix 4E Preliminary final report Period ending 30 June 2009

ImpediMed Ltd - Appendix 4E ABN 65 089 705 144 Preliminary final report Current Financial Period Ended: 30 June 2009 Previous Corresponding Reporting Period: 30 June 2008 The information contained in this document should be read in conjunction with the ImpediMed Limited Financial Report for the year ended 30 June 2009 and any public announcements made by ImpediMed Limited and its controlled entities during the year in accordance with continuous disclosure obligations arising under the ASX Listing Rules.

==> picture [435 x 383] intentionally omitted <==

----- Start of picture text -----

1 Results for announcement to the market
Previous
Current reporting corresponding
period period
$ $
1.1 Revenue from ordinary activities 3,271,138 2,994,285
Increase (decrease) in revenue: 276,853
Percentage increase (decrease): 9%
Note : With respect to the increase in revenue from ordinary activities:
- Medical Device sales to external customers increased from $1,071K to $1,377K
- Medical business device leases (incl L-Dex) increased from $74K to $215K
- Test & Measurement division revenue increased from $1,110K to $1,195K
- Finance Income dropped from $653K to $279K
1.2 Profit/(loss) from ordinary activities after tax
attributable to members (14,027,655) (9,754,128)
Increase/(decrease) in loss from ordinary
activities after tax attributable to members: 4,273,527
Percentage increase/(decrease): 44%
Note : Refer to the Directors' Report for a more extensive analysis, but in summary:
- Movement in exchange rate impact on US business loss ($1,308K)
- External R&D Project costs increase ($1,100K)
- Reduced Grant Income ($801K)
- Increased Salaries and Benefits (excluding exchange impact) ($774K)
1.3 Net profit/(loss) for the period attributable to members (14,027,655) (9,754,128)
Increase/(decrease) in net loss for the period
attributable to members: 4,273,527
Percentage increase/(decrease): 44%
Note: Refer to 1.2 above and to the Directors' Report
----- End of picture text -----

Appendix 4E Preliminary final report Period ending 30 June 2009

2		Dividends
	2.1	Dividends	NIL
		There were no dividends declared and paid during the	reporting period on ordinary shares.
		There were no dividends proposed and not yet recognised as a liability during the reporting period.
	2.2	Dividend Record Date	Not applicable
3		Financial Statements
	3.1	Consolidated balance sheet
		Refer to the 2009 Financial Report
	3.2	Consolidated income statement
		Refer to the 2009 Financial Report
	3.2	Consolidated cash flow statement
		Refer to the 2009 Financial Report
	3.3	Retained earnings
		Refer to the Statement of Changes in Equity in the 2009 Financial Report for movements in retained
		earnings.

4 Net tangible assets per security

			Previous
		Current reporting	corresponding
		period	period
		$	$
	Net tangible assets	6,265,179	8,974,148
	Issued share capital at reporting date	61,484,475	50,809,291
			Previous
		Current reporting	corresponding
		period	period
	Number of shares on issue at reporting date	98,003,501	81,718,857
	Net tangible assets per security	0.06	0.11
5	Earnings per security
			Previous
		Current reporting	corresponding
		period	period
	Weighted average number of ordinary shares (excluding reserved
	shares) for basic earnings per share	88,723,183	65,288,401
			Previous
		Current reporting	corresponding
		period	period
	Loss per share from continued operations
	Basic EPS	(0.16)	(0.15)
	Loss per share from profit attributable to ordinary shares
	Basic EPS	(0.16)	(0.15)

Diluted earnings per share has been determined to be the same as basic earnings per share as the actual calculation is anti-dilutive for both periods presented.

Refer to Note 11 on page 54 of the attached Financial Report for additional information pertaining to EPS for the current reporting period.

Appendix 4E Preliminary final report Period ending 30 June 2009

6	Acquisitions and divestments
	There were no entities over which control has been gained or lost during the current reporting period.
7	Foreign entities
	Not applicable.
8	Associates and joint ventures
	Not applicable.
9	Commentary on results for the financial year
	Refer to the 2009 Financial Report.
10	Audited Report
	The report is based on audited accounts, which are not subject to dispute or qualification.